维普中文期刊产品整合服务
2篇 您的检索式:作者名="Suad Hamad"
    题名 作者 年代 出处 被引量
1Five-year retrospective hospital-based study on epidemiological data regarding human leishmaniasis in West Kordofan state,Sudan显示文摘BACKGROUND Leishmaniasis is a neglected zoonotic disease,endemic in Sudan.Estimating this disease is very important to inform the health care policymakers and the governments to apply proper health and economic policies.AIM To find out the frequency and distribution of human leishmaniasis based on sex and age for 5 years in the West Kordofan state,Sudan.METHODS A 5-year retrospective study from 2016 through 2020 was carried out using local hospital records of leishmaniasis patients.The positive results were recorded after performing at least one of the following leishmaniasis standard tests:direct agglutination test,enzyme-linked immunosorbent assay and leishmania skin test.The sex and age of each patient were recorded.The collected data were analyzed using STATA package version 16.RESULTS A total of 162443 patient records from 2016 to 2020 were retrieved.Of these,4.39%were found to be positive for leishmaniasis.The disease has been more common in males(65.3%)than in females(34.7%).The highest reported prevalence(6.58%)was in patients 15-44 years,and the lowest prevalence(1.95%)was among patients≥65 years.CONCLUSION The results of the current study indicate that leishmaniasis is endemic in the study area even though the numbers of patients in the 5 consecutive years were varying.In addition,the disease was common in males and adults.The interpretation of these findings should take into consideration the absence of information about some important confounding factors.Abdullah Abdulslam Abdullah Musa Ahmed Ahmed Gadeed Adam Eltayeb Safa Ahmed Suad Hamad Mohammed Hussein 2022World Journal of Clinical Infectious Diseases2022,12,2:0
2Prevalence of human leishmaniasis in Sudan: A systematic review and meta-analysis显示文摘BACKGROUND There are three main forms of leishmaniasis in humans:cutaneous leishmaniasis(CL),visceral leishmaniasis(VL),and mucocutaneous leishmaniasis.The prevalence of human leishmaniasis varies widely in different countries and different regions of the same country.To date,there is no overall estimation of the prevalence of human leishmaniasis in Sudan.AIM To determine the pooled prevalence of human leishmaniasis and the disease risk factors among Sudanese citizens.METHODS From all articles written in English or Arabic languages conducted before the 4th of August 2021 from[Scopus,Web of Science,PubMed,and MEDLINE,African Journals Online(AJOL),ResearchGate,direct Google search,Google Scholar,and universities websites], just 20 articles with a total of 230960 participants were eligible for thisstudy. Data synthesis and analysis were done using STATA software, version 16. EndNotecitation manager version X9.3.3 and Reference Citation Analysis (RCA) were used to remove theduplicated studies and manage the citation respectively.RESULTSThe overall pooled prevalence of human leishmaniasis in Sudan was 21% (with confidence interval12%-30%). CL was the most common type of leishmaniasis in Sudan, with a pooled prevalence of26% followed by VL (18%). Nevertheless, the pooled prevalence of human leishmaniasis in Sudanwas higher in males compared with females (60% vs 40%). The current results revealed that thepeople in the age group between 15 and 44 were the most affected group (60%), and central Sudanhas the highest pooled prevalence of human leishmaniasis (27%) compared with other regions ofSudan. Finally, the prevalence of human leishmaniasis seems to decrease with time.CONCLUSIONThis study showed that human leishmaniasis infection is still endemic in many regions in Sudanand highly prevalent in central and eastern Sudan, and CL is the most prevalent in the country.Males and adults were more susceptible to infection compared with females and children.However, the human leishmaniasis prevalence decreased relatively over time.Musa Ahmed Abdullah Abdulslam Abdullah Idris Bello Suad Hamad Aboelgassim Bashir 2022World Journal of Methodology2022,12,4:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费